CenterStar Asset Management’s AbbVie ABBV Stock Holding History

CenterStar Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,695	Closed	-$1.04M	–	306
2023 Q2	$1.04M	Buy	+7,695	New	+$1.13M	0.11%	119
2022 Q1	–	Hold	0	–	–	–	572
2021 Q4	–	Hold	0	–	–	–	315
2021 Q1	–	Hold	0	–	–	–	481
2020 Q4	–	Hold	0	–	–	–	578
2020 Q3	–	Hold	0	–	–	–	314
2020 Q2	–	Hold	0	–	–	–	449
2018 Q4	–	Hold	0	–	–	–	52
2018 Q3	–	Hold	0	–	–	–	42

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

CenterStar Asset Management's ABBV Position: Q3 2023 in Review

CenterStar Asset Management sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 7,695 shares — an estimated $1.04M sold.

CenterStar Asset Management first reported a position in ABBV in Q2 2023 and held it in 1 quarter. The position peaked at $1.04M in Q2 2023. 3,109 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

CenterStar Asset Management reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
CenterStar Asset Management sold 7,695 AbbVie shares in Q3 2023, an estimated $1.04M.
CenterStar Asset Management first reported a position in AbbVie in Q2 2023 and held it in 1 quarter.
CenterStar Asset Management's AbbVie position peaked at $1.04M in Q2 2023.
3,109 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on CenterStar Asset Management's 13F filing for Q3 2023, filed 19 Oct 2023.